SINGULAIR

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Malta, Mexico, Netherlands, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug SINGULAIR contains one active pharmaceutical ingredient (API):

1 Montelukast
UNII U1O3J18SFL - MONTELUKAST SODIUM

Montelukast is an orally active compound which binds with high affinity and selectivity to the CysLT1 receptor. Τhe CysLT type-1 (CysLT1) receptor is found in the human airway (including airway smooth muscle cells and airway macrophages) and on other pro-inflammatory cells (including eosinophils and certain myeloid stem cells). CysLTs have been correlated with the pathophysiology of asthma and allergic rhinitis.

Read about Montelukast

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
SINGULAIR Tablet / Chewable Tablet / Granule FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
R03DC03 Montelukast R Respiratory system → R03 Drugs for obstructive airway diseases → R03D Other systemic drugs for obstructive airway diseases → R03DC Leukotriene receptor antagonists
Discover more medicines within R03DC03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 525502001116218, 525502002112216, 525502003119214, 525502004115212, 525502005111210, 525502006118219, 525502007130311, 525502008137318
Country: CA Health Products and Food Branch Identifier(s): 02238216, 02238217, 02243602, 02247997
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 00364392, 00894813, 00894836, 01017534, 01017540, 01017557, 01160355, 01160361, 01160450, 01160473, 01160533, 01999744, 02286199, 02457666, 02457672, 02457689, 02471169, 02471181, 03644844, 03644867, 03644896, 03963213, 04073881, 04073898, 04073906, 04788108, 04788114, 04847070, 04847087, 04847093, 05523725, 05523731, 05523748, 05525492, 05525500, 05525517, 05748714, 06976469, 07578280, 08758541, 08758570, 09166825, 12738952, 14357303, 16023196, 16569498, 16569506, 16569512, 17448302
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 21.834-1-01-05, 21.835-1-01-05, 25.461-11-03, 25.630-04-04
Country: EE Ravimiamet Identifier(s): 1011283, 1077320, 1077331, 1077364, 1084520, 1084531, 1111082, 1454723, 1454734, 1454745, 1457872, 1457883, 1457894, 1457906, 1457917, 1457928, 1457939, 1457940, 1457951, 1457962, 1457973
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 61979, 61980, 63673, 65429, 7956, 7956IP, 7956IP1, 7956IP2, 7956IP3, 7957, 7957IP, 7957IP1, 7957IP2, 7957IP3, 8780
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 011526, 021048, 021345
Country: FR Base de données publique des médicaments Identifier(s): 62746747, 63842168, 64374772, 64561462, 64708962, 65324797, 67128676, 68069647, 69863646
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 140029, 140031, 140035, 143645, 143657, 143678, 21458, 21493, 21500, 373480, 373535, 373564, 377648, 67422
Country: HK Department of Health Drug Office Identifier(s): 43332, 43333, 47118, 51616
Country: HR Agencija za lijekove i medicinske proizvode Identifier(s): HR-H-436317310, HR-H-490892692, HR-H-556066749
Country: IE Health Products Regulatory Authority Identifier(s): 46237, 46334, 46542, 73002, 73011, 73013, 73091
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 3640, 3641, 4748, 6230
Country: IT Agenzia del Farmaco Identifier(s): 034001014, 034001026, 034001053, 034001216, 042170011, 043072014, 043637014, 043948013, 043948025, 043949015, 043954015
Country: JP 医薬品医療機器総合機構 Identifier(s): 4490026C1030, 4490026F1052, 4490026F2059, 4490026F3039, 4490026F4035
Country: MT Medicines Authority Identifier(s): AA908/13504, PI908/13501A, PI908/13502A, PI908/13503A
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 057M2002, 356M97, 357M97
Country: NL Z-Index G-Standaard, PRK Identifier(s): 52043, 52051, 67857, 90182
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100001350, 100082621, 100101985, 100209665
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W68217001, W68217002, W68218001, W68218002, W68297001, W68297002, W68297003, W68297004, W68298001, W68298002, W68298003, W68298004, W68298005, W68298006, W68298007, W68298008, W68298009, W68298010, W68298011, W68298012, W68298013, W68298014, W68298015
Country: SG Health Sciences Authority Identifier(s): 09768P, 09769P, 11641P, 12460P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 3443041, 7013083, 7013084, 7013085
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699636080108, 8699636080122, 8699636090800
Country: US FDA, National Drug Code Identifier(s): 0006-1711, 0006-3841, 0006-9117, 0006-9275
Country: ZA Health Products Regulatory Authority Identifier(s): 32/10.2.2/0322, 35/10.2.2/0397, A38/10.2.2/0584

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.